MBP metabolic pharmaceuticals limited

investment in polynovo, page-7

  1. 5,318 Posts.
    lightbulb Created with Sketch. 253
    Yep, and Billgeld's utter disgust at Xceed for what looks like a real mismanagement of their Polynovo asset for years is entirely understandable. They failed miserably in building value 2004-2007.

    As a long-time holder of Metabolic shares, when I saw the familiar name of David Kenley listed as CEO until just last March, I admit to an unsettling feeling of deja vu.


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.